IMI Impact on antimicrobial resistance
Van derden31/05/24
On 31 May 2024 from 14:00 CET to 15:30 CET, the Innovative Health Initiative is organising an online event ‘IMI Impact on antimicrobial resistance’. The goal of this event is to highlight the impacts that the COMBACTE projects are having in tackling antimicrobial resistance (AMR). AMR is considered to be one of the top global public health and development threats, and it’s estimated to cause more than 35 000 deaths per year in the EU. Despite this, few new antibiotics make it onto the market, meaning that there is an urgent need for innovative antimicrobials to treat resistant infections.
Find out more and register here.
